Daugherty, Joseph F.,Palmer, John R.,Tempesta, Michael S.
申请号：
AU2008261094
公开号：
AU2008261094B2
申请日:
2008.06.04
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
An oral creatine formulation includes soluble creatine and polyethylene glycol,coated with an enteric coating. The most preferred soluble creatine is creatineHCl. The most preferred polyethylene glycols have an average molecular weightof from 3150 to 3685, although for particular formulation formulations and particularuses, the average molecular weight polyethylene glycols may range from 190 to9000.
